ResMed invests in R&D
By HME News Staff
Updated 9:32 AM CDT, Mon August 22, 2022
SAN DIEGO – ResMed has officially opened a new technology R&D facility in Sandyford in Dublin, alongside Tánaiste Leo Varadkar, to support innovation, technology development and product development. The company is investing 30 million euros in the facility, doubling its Ireland-based software and technology team with 70 jobs over the next four years, including high-skilled, high-paying roles such as mobile, AWS and full-stack software developers and algorithm/machine learning engineers. “I’m thrilled to be in Dublin to officially open this state-of-the-art R&D facility,” said Mick Farrell, CEO. “This investment will support the continued growth of ResMed’s product portfolio to meet the needs of patients across Ireland, Europe, and the world. It will also create new capabilities and skills within our expanding team in Ireland and support our global innovation strategy.” Many of ResMed’s digital innovations are developed or enhanced by the company’s Ireland-based “ResMed Sensor Technologies” division. ResMed’s investment is supported by the Irish Government through IDA Ireland.
Comments